35
Participants
Start Date
March 3, 2025
Primary Completion Date
April 22, 2025
Study Completion Date
April 22, 2025
ALLERSPRAY-G (device A)
Symptomatic treatment consists of 3 sprays of medical device A in each nostril while breathing in slightly. This process should be repeated 4 times a day for 14 days by patients participating in the study.
PCNS (device B)
Symptomatic treatment consists of 3 sprays of medical device B in each nostril while breathing in slightly. This process should be repeated 4 times a day for 14 days by patients participating in the study.
CHU Clermont-Ferrand, Clermont-Ferrand
Vitrobio
INDUSTRY
University Hospital, Clermont-Ferrand
OTHER